{
    "title": "UK cost agency rejects British company GW's cannabis drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2784710/UK-cost-agency-rejects-British-company-GWs-cannabis-drug.html",
    "date": "2014-10-08",
    "keywords": [
        "drug",
        "cost",
        "gw",
        "health",
        "care",
        "sativex",
        "cannabis",
        "ms",
        "treatment",
        "agency",
        "company",
        "gws",
        "october",
        "sclerosis",
        "nice",
        "state",
        "country",
        "marijuana",
        "gmt",
        "email",
        "ben",
        "hirschlerlondon",
        "firm",
        "spasticity",
        "companys",
        "home",
        "institute",
        "excellence",
        "service",
        "percent",
        "trading",
        "newssativex",
        "tongue",
        "location",
        "countryside",
        "prescription",
        "britain",
        "partner",
        "group",
        "bayerit",
        "licence",
        "key",
        "determinant",
        "view",
        "value",
        "money",
        "event",
        "review",
        "variety",
        "cooper",
        "consultant",
        "neurologist",
        "manchester",
        "neuroscience",
        "centre",
        "guideline",
        "groupnice",
        "fampyra",
        "biogen",
        "idecwith",
        "patient",
        "day",
        "limit",
        "sprayswe",
        "think",
        "shame",
        "science",
        "england",
        "spokesman",
        "reach",
        "legalisation",
        "colorado",
        "industrygw",
        "ability",
        "use",
        "way",
        "record",
        "year",
        "epidiolex",
        "hardtotreat",
        "dollar",
        "pound",
        "editing",
        "mark",
        "potterkeith",
        "weir"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}